A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

NCT05633459 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Multiple ascending doses of QRL-201
DRUG: Multiple ascending doses of Placebo
DRUG: QRL-201
DRUG: Placebo
DRUG: QRL-201

Sponsor

QurAlis Corporation